(Q35667342)

9 August 2017

title

Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers (English)

1 reference

cytochrome P-450 CYP3A inhibitors

9 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

23 June 2024

author name string

Warren Tong

2

1 reference

9 August 2017

Janessa Mount

3

1 reference

9 August 2017

May Garrett

5

1 reference

9 August 2017

Brian Hee

6

1 reference

9 August 2017

Paulina Selaru

7

1 reference

9 August 2017

Nenad Sarapa

8

1 reference

9 August 2017

Yazdi K. Pithavala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

23 June 2024

Sadayappan V. Rahavendran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

23 June 2024

Karen J. Klamerus

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

23 June 2024

language of work or name

1 reference

26 August 2010

1 reference

full work available at URL

9 August 2017

https://link.springer.com/content/pdf/10.1007/s10637-010-9511-6.pdf

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20740300/pdf/?tool=EBI

23 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20740300/?tool=EBI

23 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

https://europepmc.org/articles/PMC3256319

23 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

https://europepmc.org/articles/PMC3256319?pdf=render

23 June 2024

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740300

https://link.springer.com/content/pdf/10.1007/s10637-010-9511-6.pdf

23 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S10637-010-9511-6

https://link.springer.com/article/10.1007/s10637-010-9511-6/fulltext.html

23 June 2024

1 reference

https://api.crossref.org/works/10.1007/S10637-010-9511-6

http://www.springerlink.com/index/pdf/10.1007/s10637-010-9511-6

23 June 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S10637-010-9511-6

Investigational New Drugs

23 June 2024

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

273-281

1 reference

https://scigraph.springernature.com/pub.10.1007/s10637-010-9511-6

9 August 2017

exact match

0 references

cites work

Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256319

Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma

12 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9511-6

Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9511-6

The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9511-6

Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20740300

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference